https://www.live-feeds.com/feed/high-cost-of-glp-1s-drives-some-to-seek-cheaper-unregulated-versionsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/high-cost-of-glp-1s-drives-some-to-seek-cheaper-unregulated-versionshttps://www.live-feeds.com/feed/high-cost-of-glp-1s-drives-some-to-seek-cheaper-unregulated-versions#u114357Sat, 10 Oct 2026 14:40:30 +0000Steep prices for GLP-1 medications are driving some consumers to seek cheaper, unregulated alternatives. More than 15 million people use GLP-1 drugs across America, creating a massive market demand alongside an unprecedented consumer overlay that drugmakers are tapping into. While manufacturers utilize pharmacy counter discounts to manage spending, the financial burden remains a central issue for a majority of users. These economic pressures highlight ongoing challenges with affordability and access within the current pharmaceutical market.Why it mattersThe widespread adoption of GLP-1 medicat